AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Tipranks

Published November 3, 2026

Filament Ships PEX010 to USC for Psychedelic Therapy Trial - TipRanks.com

Read the full story at Tipranks

Filament Health shipped its PEX010 botanical psilocybin drug candidate to USC's Keck School of Medicine for the Mindfulness Assisted Psychedelic.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelics